About ArcherDX
ArcherDX is a company based in Boulder (United States) founded in 2013 by John Iafrate and Long Phi Le was acquired by Invitae in June 2020.. ArcherDX has raised $152.6 million across 3 funding rounds from investors including Invitae, Driehaus and Perceptive Advisors. The company has 429 employees as of December 31, 2022. ArcherDX has completed 1 acquisition, including Baby Genes. ArcherDX operates in a competitive market with competitors including Guardant Health, Natera, Foundation Medicine, Prenetics and Veracyte, among others.
- Headquarter Boulder, United States
- Employees 429 as on 31 Dec, 2022
- Founders John Iafrate, Long Phi Le
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Archerdx, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of ArcherDX
ArcherDX has successfully raised a total of $152.6M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $55 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series C — $55.0M
-
First Round
First Round
(20 Mar 2018)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2019 | Amount | Series C - ArcherDX | Valuation | Perceptive Advisors | |
| May, 2019 | Amount | Series B - ArcherDX | Valuation | Perceptive Advisors | |
| Mar, 2018 | Amount | Series A - ArcherDX | Valuation | Boulder Ventures , PBM Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ArcherDX
ArcherDX has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Invitae, Driehaus and Perceptive Advisors. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
PE firm investing in the US
|
Founded Year | Domain | Location | |
|
Venture capital is offered by Boulder Ventures for innovative companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ArcherDX
ArcherDX has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Baby Genes. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Genomic diagnostic solutions for neonates and carrier testing are provided.
|
2013 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - ArcherDX
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Archerdx Comparisons
Competitors of ArcherDX
ArcherDX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Foundation Medicine, Prenetics and Veracyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Archerdx
Frequently Asked Questions about ArcherDX
When was ArcherDX founded?
ArcherDX was founded in 2013 and raised its 1st funding round 5 years after it was founded.
Where is ArcherDX located?
ArcherDX is headquartered in Boulder, United States. It is registered at Boulder, Colorado, United States.
Is ArcherDX a funded company?
ArcherDX is a funded company, having raised a total of $152.6M across 3 funding rounds to date. The company's 1st funding round was a Series A of $37.6M, raised on Mar 20, 2018.
How many employees does ArcherDX have?
As of Dec 31, 2022, the latest employee count at ArcherDX is 429.
What does ArcherDX do?
ArcherDX was founded in 2013 in Boulder, United States, within the biotechnology sector. Patented Anchored Multiplex PCR (AMP) technology is employed to create in-vitro diagnostics and Personalized Cancer Monitoring products for identifying solid tumor biomarkers. Operations focus on molecular diagnostics for oncology, with a product pipeline that includes ArcherMET, NTRK CDx, and Fusion Plex.
Who are the top competitors of ArcherDX?
ArcherDX's top competitors include Guardant Health, Exact Sciences and Foundation Medicine.
How many acquisitions has ArcherDX made?
ArcherDX has made 1 acquisition, including Baby Genes.
Who are ArcherDX's investors?
ArcherDX has 10 investors. Key investors include Invitae, Driehaus, Perceptive Advisors, ArrowMark Partners, and Soleus Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.